Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2017-07-21FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)
The FDA approved a supplemental application for ZESTORETIC (lisinopril and hydrochlorothiazide) by Almatica Pharma Inc., resulting in update…
-
FDA label_change · 2017-02-21FDA Approved: DOXAZOSIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for doxazosin mesylate from Aurobindo Pharma Limited, resulting in a labeling update for the product…
-
FDA label_change · 2016-11-18FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for Cardizem LA (diltiazem hydrochloride extended-release) submitted by Bausch Health US LLC.
-
FDA label_change · 2016-06-29FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
FDA has approved a supplemental application for Cardizem CD (diltiazem hydrochloride) filed by Bausch Health US LLC under NDA 020062.
-
FDA label_change · 2016-04-08FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (EXELA PHARMA SCIENCES, LLC)
FDA approved a supplemental application for verapamil hydrochloride, resulting in changes to its labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2016-03-24FDA Approved: EDARBI — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for EDARBI (azilsartan kamedoxomil) submitted by Azurity Pharmaceuticals, Inc., updating the product…
-
FDA label_change · 2016-02-18FDA Approved: LISINOPRIL — Supplemental Application (Exelan Pharmaceuticals Inc.)
The FDA approved a supplemental application for lisinopril submitted by Exelan Pharmaceuticals Inc., typically resulting in labeling updates…
-
FDA label_change · 2015-10-13FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for clonidine hydrochloride by Actavis Pharma, Inc., indicating changes to the approved product …
-
FDA label_change · 2015-07-27FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplement for Diovan HCT (valsartan with hydrochlorothiazide) submitted by Novartis, updating the product labeling.
-
FDA label_change · 2015-07-27FDA Approved: DIOVAN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for DIOVAN (valsartan) submitted by Novartis Pharmaceuticals Corporation, resulting in changes to th…
-
FDA label_change · 2015-06-29FDA Approved: BISOPROLOL FUMARATE — Supplemental Application (Natco Pharma USA LLC)
FDA approved a supplemental application for Bisoprolol Fumarate (Natco Pharma USA LLC), resulting in labeling changes for the product.
-
FDA label_change · 2015-06-08FDA Approved: CARDURA XL — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for CARDURA XL (doxazosin mesylate) by Viatris Specialty LLC, typically resulting in labeling change…
-
FDA label_change · 2015-05-22FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA is processing a supplemental application for EXFORGE (amlodipine besylate and valsartan) from Novartis Pharmaceuticals, related to a lab…
-
FDA label_change · 2015-05-18FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) from Novartis, resulting in changes to…
-
FDA label_change · 2015-05-06FDA Approved: GUANFACINE — Supplemental Application (PuraCap Laboratories LLC dba Blu Pharmaceuticals)
FDA approved a supplemental application for guanfacine from PuraCap Laboratories dba Blu Pharmaceuticals.
-
FDA label_change · 2015-03-23FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental labeling application for Cardizem LA (diltiazem hydrochloride extended-release tablets) from Bausch Health US LL…
-
FDA label_change · 2014-12-31FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) submitted by Novartis Pharmaceuticals …
-
FDA label_change · 2014-12-12FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for Benazepril hydrochloride and hydrochlorothiazide (Padagis US LLC), resulting in updated labeling…
-
FDA label_change · 2014-09-30FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) from Organon LLC.
-
FDA label_change · 2014-09-26FDA Approved: CARVEDILOL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for carvedilol submitted by Glenmark Pharmaceuticals USA, resulting in changes to the drug’s lab…
-
FDA label_change · 2014-09-24FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for EXFORGE (amlodipine besylate and valsartan) from Novartis Pharmaceuticals Corporation, updat…
-
FDA label_change · 2014-09-23FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc., …
-
FDA label_change · 2014-08-14FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for the benazepril hydrochloride and hydrochlorothiazide combination (Padagis US LLC), resulting in …
-
FDA label_change · 2014-07-23FDA Approved: EDARBI — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for EDARBI (azilsartan kamedoxomil) submitted by Azurity Pharmaceuticals, Inc.
-
FDA label_change · 2014-07-22FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for Benazepril hydrochloride and hydrochlorothiazide to update the product labeling.